SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-19-000732
Filing Date
2019-08-08
Accepted
2019-08-08 16:32:03
Documents
54
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q espr-20190630x10q.htm   iXBRL 10-Q 1293418
2 EXHIBIT 31.1 espr-20190630ex3118e8556.htm EX-31.1 15072
3 EXHIBIT 31.2 espr-20190630ex3129e3758.htm EX-31.2 14927
4 EXHIBIT 32.1 espr-20190630ex3215d8ed8.htm EX-32.1 9819
  Complete submission text file 0001410578-19-000732.txt   5608779

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA espr-20190630.xsd EX-101.SCH 39134
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE espr-20190630_cal.xml EX-101.CAL 46207
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE espr-20190630_def.xml EX-101.DEF 145783
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE espr-20190630_lab.xml EX-101.LAB 419765
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE espr-20190630_pre.xml EX-101.PRE 279389
10 EXTRACTED XBRL INSTANCE DOCUMENT espr-20190630x10q_htm.xml XML 1025192
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35986 | Film No.: 191010035
SIC: 2834 Pharmaceutical Preparations